Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry.

The clinical trial will include a control group (waiting list).

Patients who meet eligibility requirements will be assigned to control group or intervention group.

Psychological intervention will consist in an 8-session individual face-to-face delivered ACT-based treatment.

The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up.

Inclusion Criteria:

• Patients with chronic kidney disease on haemodialysis
• Older than 18 years-old
• At least 3 months on haemodialysis
• HADS Global Scale Score ≥14

Exclusion Criteria:

• Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
• Antidepressant drugs consume
• Insufficient understanding of Spanish.
• Patients who are in the Advanced Chronic Kidney Disease Unit
• Receiving other psychological treatment